Search Results - "Mouton, W."

Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis by Schuts, Emelie C, BSc, Hulscher, Marlies E J L, Prof, Mouton, Johan W, Prof, Verduin, Cees M, MD, Stuart, James W T Cohen, MD, Overdiek, Hans W P M, PharmD, van der Linden, Paul D, PharmD, Natsch, Stephanie, Pharm D, Hertogh, Cees M P M, Prof, Wolfs, Tom F W, MD, Schouten, Jeroen A, MD, Kullberg, Bart Jan, Prof, Prins, Jan M, Prof

“…Summary Background Antimicrobial stewardship is advocated to improve the quality of antimicrobial use. We did a systematic review and meta-analysis to assess…”
Get full text

Invasive Aspergillosis by Aspergillus flavus : Epidemiology, Diagnosis, Antifungal Resistance, and Management by Rudramurthy, Shivaprakash M, Paul, Raees A, Chakrabarti, Arunaloke, Mouton, Johan W, Meis, Jacques F

“…is the second most common etiological agent of invasive aspergillosis (IA) after . However, most literature describes IA in relation to or together with other…”
Get full text

Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives by de Velde, Femke, Mouton, Johan W., de Winter, Brenda C.M., van Gelder, Teun, Koch, Birgit C.P.

“…[Display omitted] Because of increasing antimicrobial resistance and the shortage of new antibiotics, there is a growing need to optimize the use of old and…”
Get full text

Combination therapy for carbapenem-resistant Gram-negative bacteria by Paul, Mical, Carmeli, Yehuda, Durante-Mangoni, Emanuele, Mouton, Johan W, Tacconelli, Evelina, Theuretzbacher, Ursula, Mussini, Cristina, Leibovici, Leonard

“…Carbapenem-resistant Gram-negative bacteria (CR-GNB) represent an increasing hazard in healthcare settings. A central question concerning the treatment of…”
Get full text

Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria by van Ingen, Jakko, Boeree, Martin J, van Soolingen, Dick, Mouton, Johan W

“…Abstract Nontuberculous mycobacteria (NTM) are increasingly recognized as causative agents of opportunistic infections in humans. For most NTM infections the…”
Get full text

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions by Roberts, Jason A, Prof, Abdul-Aziz, Mohd H, BPharm, Lipman, Jeffrey, Prof, Mouton, Johan W, Prof, Vinks, Alexander A, Prof, Felton, Timothy W, Dr, Hope, William W, Prof, Farkas, Andras, Dr, Neely, Michael N, MD, Schentag, Jerome J, Dr, Drusano, George, Prof, Frey, Otto R, Dr, Theuretzbacher, Ursula, Dr, Kuti, Joseph L, Dr

“…Summary Infections in critically ill patients are associated with persistently poor clinical outcomes. These patients have severely altered and variable…”
Get full text

Time-kill kinetics of antibiotics active against rapidly growing mycobacteria by Ferro, Beatriz E, van Ingen, Jakko, Wattenberg, Melanie, van Soolingen, Dick, Mouton, Johan W

“…This study was conducted to generate basic pharmacodynamic information on the relationship between antibiotic concentrations and the growth of rapidly growing…”
Get full text

Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus by Nation, Roger L, Prof, Li, Jian, Prof, Cars, Otto, Prof, Couet, William, Prof, Dudley, Michael N, Pharm D, Kaye, Keith S, Prof, Mouton, Johan W, Prof, Paterson, David L, Prof, Tam, Vincent H, Prof, Theuretzbacher, Ursula, PhD, Tsuji, Brian T, Pharm D, Turnidge, John D, Prof

“…Summary In the face of diminishing therapeutic options for the treatment of infections caused by multidrug-resistant, Gram-negative bacteria, clinicians are…”
Get full text

Staphylococcus aureus internalization impairs osteoblastic activity and early differentiation process by Mouton, W., Josse, J., Jacqueline, C., Abad, L., Trouillet-Assant, S., Caillon, J., Bouvard, D., Bouchet, M., Laurent, F., Diot, A.

“…Staphylococcus aureus is the most frequent aetiology of bone and joint infections (BJI) and can cause relapsing and chronic infections. One of the main factors…”
Get full text

Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus by Arendrup, Maiken Cavling, Verweij, Paul E, Mouton, Johan W, Lagrou, Katrien, Meletiadis, Joseph

“…Azole-resistant Aspergillus fumigatus is emerging worldwide. Reference susceptibility testing methods are technically demanding and no validated commercial…”
Get full text

MIC-based dose adjustment: facts and fables by Mouton, Johan W, Muller, Anouk E, Canton, Rafael, Giske, Christian G, Kahlmeter, Gunnar, Turnidge, John

“…Over recent decades, several publications have described optimization procedures for antibiotic therapy in the individual patient based on antimicrobial MIC…”
Get full text

Protein Binding: Do We Ever Learn? by ZEITLINGER, Markus A, DERENDORF, Hartmut, MOUTON, Johan W, CARS, Otto, CRAIG, William A, ANDES, David, THEURETZBACHER, Ursula

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia by Muller, Anouk E, Punt, Nieko, Mouton, Johan W

“…The %fT>MIC of ceftazidime has been shown to correlate with microbiological outcome of Gram-negative bacteria (GNB) in preclinical studies. However, clinical…”
Get full text

Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? by Chisholm, Stephanie A., Mouton, Johan W., Lewis, David A., Nichols, Tom, Ison, Catherine A., Livermore, David M.

“…Background Gonorrhoea has been among the easiest infections to cure with antibiotics. Nevertheless, emerging resistance has driven repeated treatment shifts…”
Get full text

Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration by Laterre, Pierre-François, Wittebole, Xavier, Van de Velde, Sebastien, Muller, Anouk E, Mouton, Johan W, Carryn, Stéphane, Tulkens, Paul M, Dugernier, Thierry

“…The growing incidence of infections caused by Enterobacteriaceae producing ESBLs has led to increased use of carbapenems. Temocillin, which resists most…”
Get full text

Consumption of antimicrobials in pigs, veal calves, and broilers in the Netherlands: quantitative results of nationwide collection of data in 2011 by Bos, Marian E H, Taverne, Femke J, van Geijlswijk, Ingeborg M, Mouton, Johan W, Mevius, Dik J, Heederik, Dick J J

“…In 2011, Dutch animal production sectors started recording veterinary antimicrobial consumption. These data are used by the Netherlands Veterinary Medicines…”
Get full text

Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints by de Velde, Femke, de Winter, Brenda C M, Koch, Birgit C P, van Gelder, Teun, Mouton, Johan W

“…To describe the population pharmacokinetics of oral amoxicillin and to compare the PTA of current dosing regimens. Two groups, each with 14 healthy male…”
Get full text

In Vitro Antifungal Susceptibility Testing of Candida Isolates with the EUCAST Methodology, a New Method for ECOFF Determination by Meletiadis, J, Curfs-Breuker, I, Meis, J F, Mouton, J W

“…The susceptibilities of 1,099 molecularly identified clinical isolates against 8 antifungal drugs were determined using the EUCAST microdilution method. A new…”
Get full text

The Pharmacokinetics and Pharmacodynamics of Pulmonary Mycobacterium avium Complex Disease Treatment by INGEN, Jakko Van, EGELUND, Eric F, LEVIN, Adrah, TOTTEN, Sarah E, BOEREE, Martin J, MOUTON, Johan W, AARNOUTSE, Rob E, HEIFETS, Leonid B, PELOQUIN, Charles A, DALEY, Charles L

“…Currently recommended multidrug treatment regimens for Mycobacterium avium complex (MAC) lung disease yield limited cure rates. This results, in part, from…”
Get full text

A Novel Y319H Substitution in CYP51C Associated with Azole Resistance in Aspergillus flavus by Paul, R A, Rudramurthy, S M, Meis, J F, Mouton, J W, Chakrabarti, A

“…This study aimed to explore any mutation in the CYP51 gene conferring azole resistance in Aspergillus flavus. Two voriconazole-resistant and 45…”
Get full text